Pharmaceutical CAS 1985605-59-1baloxavir Powder Raw Baloxavir Purity Baloxavir

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-Sung Baloxavir
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Baloxavir
• Name: Baloxavir Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical Grade
• Specific: COA
• Test Method: HPLC
• CAS: 1985605-59-1
• Mf: C24h19f2n3o4s
• MW: 483.5
• Density: 1.63
• Melting Point: 644
• Transport Package: Negotiabie
• Specification: 99%
• Trademark: D-Sung
• Origin: Xi′an Shaanxi
• Production Capacity: 500kg/Month

Product Description

Pharmaceutical CAS 1985605-59-1Baloxavir powder Raw Baloxavir  Purity Baloxavir 

Product Description

Product Datails

DL-Alanine	Baloxavir
CAS:	1985607-70-2
Appearance:	White  Powder
Purity:	99%

Baloxavir marboxil is a white crystalline powder. Baloxavir marboxil is a new hat-dependent endonuclease inhibitor that kills influenza viruses within 24 hours, but some symptoms can last longer. Baloxavir marboxil inhibits virus replication by different mechanisms from existing anti-flu drugs. Oseltamivir (tamiflu), which is snapped up during flu, Baloxavir marboxil usually takes
72 hours to work.

Application&Function

Baloxavir marboxil is a new hat-dependent endonuclease inhibitor that kills influenza viruses within 24 hours, but some symptoms can last longer. Baloxavir marboxil inhibits virus replication by different mechanisms from existing anti-flu drugs. Oseltamivir (tamiflu), which is snapped up during flu, Baloxavir marboxil usually takes 72 hours to work.

Baloxavir marboxil is used to treat influenza A and influenza B infections. The drug was initially approved for marketing in Japan in February 2018, and was approved by the FDA on October 24, 2018 for the treatment of acute uncomplicated influenza patients 12 years of age and older who have symptoms for no more than 48 hours. Baloxavir marboxil is a cap endonuclease inhibitor, which has a unique mechanism of action compared with the class of neuraminidase inhibitor drugs currently used to treat influenza infections.

Specification